Navigation Links
Numira Biosciences Names New Board Member
Date:8/11/2011

SALT LAKE CITY, Aug. 11, 2011 /PRNewswire/ -- Numira Biosciences, a specialty contract research organization and leader in high resolution, 3D imaging services and visualization software for the life science market, today announced that it has appointed William M. Harrison to its Board of Directors.

Mr. Harrison currently serves as the Chief Executive Officer at VIDA Sciences, a CRO consulting firm based in Kalamazoo, Michigan.  Prior to founding VIDA Sciences, Mr. Harrison held a number of senior management positions at MPI Research, a large international CRO based in Mattawan, Michigan.  Most notably, during his last ten years at MPI, he held the position of President and Chief Operating Officer. Additionally, Mr. Harrison is an active member of the Society of Quality Assurance and serves on the Board of Trustees for the Kalamazoo Valley Community College Foundation and the Borgess Medical Center, as well as serving as a board member for the American Life Sciences Innovation Council.

"We are pleased that Bill has joined our board," said Michael Beeuwsaert, President and CEO of Numira. "His 25 years of senior management and regulatory compliance experience in a high-growth, preclinical services environment will be of great value to Numira as we move to the next level as a company."

About Numira Biosciences

Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries.  Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other areas of disease and/or therapy.  Moreover, we are a recognized leader in high-resolution, quantitative imaging for drug and device development.  Numira, a privately-held company, is venture-backed by vSpring Captital, the Tech Coa
'/>"/>

SOURCE Numira Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
2. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
3. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
4. Neurocrine Biosciences Reports Second Quarter 2011 Results
5. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
6. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
7. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
8. Cell Biosciences Changes Name to ProteinSimple
9. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
10. SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
11. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PA (PRWEB) July 30, 2014 Vycom ... family of products, designed to meet Factory Mutual (FM) ... equipment materials such as wet benches, process tools, fume ... worker safety and damage to semiconductor wafers used in ... provides a flame-retardant PVC solution with excellent workability and ...
(Date:7/30/2014)...  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), is ... technologies are used to discover, develop, manufacture and ... bio-based chemical, biopharmaceutical and industrial enzyme industries, announced ... Vice President and Chief Financial Officer. Tom will ... technology operations for Dyadic and will succeed ...
(Date:7/30/2014)... , July 30, 2014  AtheroNova Inc. (OTCBB: ... and development of compounds to safely regress atherosclerotic ... announces that its partner, CardioNova, has accomplished first ... trial with AtheroNova,s lead compound, AHRO-001.  This Phase ... AHRO-001 Phase 1 safety trial completed in February ...
(Date:7/30/2014)... Hartford, CT (PRWEB) July 30, 2014 ... economic development organization based in East Hartford, Conn., was ... on Phase II of a project that will determine ... facility in rural north-central Connecticut. USDA Rural Development provided ... (RBEG) program for the second phase of the feasibility ...
Breaking Biology Technology:Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3
... in Alexandria, VA, the Department of Health and Human ... Accountability (OGAPA) recognized the National Institutes of Health,s Commercialization ... special "team" recognition award for superior efforts to assist ... and "contributing to public health." The award was made ...
... TORONTO, ON Scientists at the University of Toronto, Stanford ... action and function of candidate prescription drugs on human cells, ... a larger scale than ever before. The researchers say ... understanding of a variety of diseases and biologic actions, and ...
... in the Materials Science and Technology division of ... injection, detection and precession of spin accumulation in ... at temperatures up to 225 degrees Celsius. These ... in Si is viable as a basis for ...
Cached Biology Technology:Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium 2University of Toronto chemistry technology promises more effective prescription drug therapies 2NRL scientists achieve high temperature milestone in silicon spintronics 2NRL scientists achieve high temperature milestone in silicon spintronics 3
(Date:7/30/2014)... Oxford University Press (OUP) is pleased to announce its ... Beginning in 2015, OUP and CINP will partner to ... ) as a fully open-access journal. , Alan Frazer, ... that the size and expertise of OUP will further ... become one of the very leading journals within neuropsychopharmacology. ...
(Date:7/30/2014)... received a pledge of $1 million from the Cornelia ... new Neurobehavioral Biometry Center. , The newly ... the Laboratory to develop a greater breadth and depth ... of accelerating the pace of research to improve human ... premier resource for the Laboratory and its external partners, ...
(Date:7/30/2014)... as simple as inserting a medicated, disappearing fabric minutes ... have discovered a potentially faster way to deliver a ... method spins the drug into silk-like fibers that quickly ... of the drug than possible with other topical materials ... women a potentially more effective, discreet way to protect ...
Breaking Biology News(10 mins):OUP to partner with the International College of Neuropsychopharmacology 2Rossi Foundation pledges $1M for JAX neurobehavioral research center 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
... frogs like to ,see what they,re getting, when they select ... Michael Reichert from the University of Wisconsin-Milwaukee in the US. ... the importance of vision on male mating behaviors in a ... journal Behavioral Ecology and Sociobiology . Animals display ...
... Shenzhen, China An international research team led by ... genomic sequence of pear by an approach using the ... genome not only provides an invaluable new resource for ... new light on the genome evolution and other genome-wide ...
... 2012 Medbox, Inc. (Ticker: MDBX) ( www.medboxinc.com ), ... have received many inquiries from shareholders purchasing shares of ... volatile trading. These inquiries were responded to and shareholders ... In other news, the company further ...
Cached Biology News:Vision stimulates courtship calls in the grey tree frog 2Pear genome provides new insight into breeding improvement and evolutionary trace analysis 2Medbox Communicates with Shareholders, Comments on Pending Transition to OTC Bulletin Board, and Announces Appearance on Fox Business News Channel 2
... SeeDNA co-precipitant, 250 ... pink color ensures easy ... nucleic acid recovery.Chemically inert, ... biology applications.Simple 5-minute protocol. ...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
Request Info...
Recombinant Mouse TGF-beta RII/(human) Fc Chimera, CF...
Biology Products: